I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Hypovolemia is a very frequent clinical situation in the Intensive Care Unit (ICU), for which the rapid fluid infusion is applied as treatment. Therefore, it is essential to have reliable tools to predict the efficacy of volume expansion (VE) and ultimately distinguish patients who may benefit from VE from those who are unlikely to respond. Recently, many studies have focused on the prediction of fluid responsiveness. Static hemodynamic indices have been of little value in predicting fluid responsiveness.\[[@ref1][@ref2]\] In contrast, dynamic indices, based on analysis of preload dependence, have been validated as factors that can help predict fluid responsiveness.\[[@ref1][@ref3][@ref4][@ref5]\] Passive leg raising (PLR) is a reversible maneuver that mimics rapid VE by shifting venous blood from the lower limbs\[[@ref6]\] toward the intrathoracic compartment.\[[@ref7][@ref8]\] Thus, PLR increases the cardiac preload and, by definition, increases the stroke volume (SV) if the heart is preload dependent.\[[@ref9][@ref10][@ref11]\] Recent studies demonstrated that PLR-induced changes in SV (PLR-ΔSV) and cardiac output (PLR-ΔCO) are reliable predictive indices of fluid responsiveness.\[[@ref12][@ref13][@ref14][@ref15][@ref16][@ref17]\] The fluid responsiveness describes the change of SV or cardiac output which varies with the preload basing on a Frank--Starling curve. However, patients with different cardiac functions show different Frank--Starling curves, especially for the patients with normal or low cardiac function. Therefore, it is not clear whether this will affect the prediction of fluid responsiveness or not, and the predictive value of PLR in patients with normal or low cardiac function has not been clearly established.

The aim of this study was to test whether systolic cardiac function can influence the diagnostic value of PLR in predicting fluid responsiveness.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

The study was conducted in accordance with the *Declaration of Helsinki* and was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (No. 2013-12-03). Informed written consent was obtained from all patients prior to their enrollment in this study.

Patients {#sec2-2}
--------

This prospective, observational study (Chinese Clinical Trial Register: ChiCTR-OCH-13004027) was carried out in the surgical ICU of the First Affiliated Hospital of Sun Yat-sen University (Guangzhou, China) from December 2013 to July 2015. The ventilated patients with presumed hypovolemia who received fluid expansion at the discretion of the attending physician were consecutively included. This decision was based on the presence of at least one clinical sign of inadequate tissue perfusion and the absence of contraindications for fluid infusion. Clinical signs of inadequate tissue perfusion were defined as follows: clinical signs of acute circulatory failure (systolic arterial pressure \[SAP\] \<90 mmHg \[or a decrease of \<40 mmHg in previously hypertensive patients\]; urine output of \<0.5 ml·kg^−1^·h^−1^ for at least 1 h; tachycardia \[heart rate \>100/min\]; mottled skin), oliguria (diuresis below 20 ml/h or 0.5 ml·kg^−1^·h^−1^), acute kidney failure, and/or clinical and laboratory signs of extracellular dehydration.\[[@ref16][@ref17]\] Exclusion criteria included clinical signs of hemorrhage, inability to defer fluid challenge for several minutes, arrhythmia, moderate or severe valvular regurgitation, a contraindication to PLR, preterminal illness with a life expectancy of less than 24 h, or known anaphylactic reactions to albumin.

Study design {#sec2-3}
------------

[Figure 1](#F1){ref-type="fig"} illustrates the design of the study. Hemodynamics (heart rate \[HR\], SAP, mean arterial pressure \[MAP\], pulse pressure \[PP\], CO, and SV) were recorded at each step of the protocol. Baseline 1 indicates that patients were in a semi-recumbent position, with the trunk elevated 30--45° relative to the lower limbs. PLR indicates that patients were in a supine position with the lower limbs elevated 30--45° relative to the trunk. Each hemodynamic measurement was recorded within the first 5 min. PLR-induced changes (PLR-Δ) are expressed in percentages as follows: 100 × (PLR value − baseline 1 value)/baseline 1 value. Baseline 2 indicates that the lower limbs and trunk were returned to baseline 1 position for at least 5 min. After hemodynamic measurements, VE was performed within 30 min by infusing 250 ml 5% albumin. Post-VE indicates that after VE, patients remained in the baseline 2 position. VE-induced changes (VE-Δ) are expressed in percentages as follows: 100 × (post-VE value − baseline 2 value)/baseline 2 value. Patients were considered responders to VE if VE-ΔSV increased by 15%. The ventilation parameters and vasoactive drugs were maintained during the study.

![Study design. Base: Baseline; PLR: Passive leg raising; VE: Volume expansion.](CMJ-131-253-g001){#F1}

Measurements {#sec2-4}
------------

The following characteristics were recorded: age, gender, Acute Physiology and Chronic Health Evaluation II score, Sequential Organ Failure Assessment score, the use of vasoactive, sedative, and analgesic drugs, indication for ICU stay, and medical history.

We used the PiCCO system (Pulsion Medical System, Munich, Germany)\[[@ref18][@ref19]\] for hemodynamic monitoring. This device allows continuous measurement of the arterial pressure (SAP, diastolic arterial pressure \[DAP\], and MAP) and HR. PP was calculated as the SAP minus the DAP. The system uses a transpulmonary-thermodilution method for measurements of volume status (global end-diastolic volume \[GEDV\]). Additionally, this system also can provide information on cardiac function, including global ejection fraction (GEF),\[[@ref20][@ref21]\] cardiac function index (CFI),\[[@ref20][@ref21][@ref22]\] and left ventricular contractility index (dp/dt max). These indicators can accurately reflect systolic cardiac function. A central venous catheter was inserted into the internal jugular vein or the subclavian vein, and a PiCCO arterial catheter was inserted into the femoral artery. Then, a series of three 15-ml ice-cold saline boluses at a temperature of \<8°C were injected into the central vein, and the associated dilution curves and various hemodynamic parameters were obtained.\[[@ref18]\] All patients received volume-controlled mechanical ventilation with positive end-expiratory pressure. Drainage of blood was \<50 ml/h in all patients, and no patient underwent repeated surgery for bleeding within 12 h postsurgery.

Statistical analysis {#sec2-5}
--------------------

The patients to be analyzed were divided into low-GEF (\<20%) and near-normal-GEF (≥20%) groups. This cutoff of 20% reflects an approximate cutoff of 40% of the ejection fraction of the left ventricle, corresponding to the low limit of normal.\[[@ref20][@ref21][@ref23]\] The Kolmogorov--Smirnov test was used to check the normality of the data distribution. All continuous variables were normally distributed and expressed as mean ± standard deviation (SD). Intergroup comparisons of continuous and categorical variables were performed with Student\'s *t*-test and the Chi-square test, respectively.

In each group, patients were classified as responders and nonresponders. Absolute values at baseline and during PLR and VE were analyzed. Comparisons before and after PLR, before and after VE, and between baseline 1 and baseline 2 were performed using a paired-sample Student\'s *t*-test. The comparison between responder and nonresponder values was performed using an independent-sample Student\'s *t*-test. The receiver-operating characteristic (ROC) curves were compared using the Hanley--McNeil test.\[[@ref24]\] Cutoff values for ΔSV, ΔCO, ΔPP, ΔSAP, ΔMAP, and ΔHR were chosen to correspond to the best respective Youden\'s index\[[@ref25]\] calculated as follows: Youden\'s index = sensitivity + specificity − 1. Threshold indicator values such as sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios were calculated for each hemodynamic indicator tested. *P* \< 0.05 was considered statistically significant. Statistical analysis was performed using SPSS 19.0 software (SPSS, Chicago, IL, USA) for all tests except the Hanley--McNeil test.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Patients\' characteristics {#sec2-6}
--------------------------

A total of 78 ventilated patients with presumed hypovolemia and considered for VE were included in the study. Of these, 38 patients were assigned to the low-GEF group (\<20%) and 40 patients were assigned to the near-normal-GEF group (≥20%). [Table 1](#T1){ref-type="table"} summarizes the clinical characteristics, ventilation settings, and hemodynamics of the two patient groups. There were no significant differences between the two groups in terms of clinical characteristics. Cardiac function parameters were significantly higher in the near-normal-GEF group than in the low-GEF group. The ventilation settings, baseline volume status, and hemodynamics were similar between the two groups, with the exception of SV, CO, SAP, and PP, which were significantly higher in the near-normal-GEF group. Additionally, CVP was significantly lower in the near-normal-GEF group than in the low-GEF group.

###### 

Descriptive characteristics of the mechanically ventilated patients considered for volume expansion

  Characteristics                       GEF \<20% (*n* = 38)   GEF ≥20% (*n* = 40)   Statistics   *P*
  ------------------------------------- ---------------------- --------------------- ------------ -------
  Age (years)                           64 ± 6                 58 ± 14               2.019\*      0.051
  Male/female                           27/11                  32/8                  0.847^†^     0.357
  APACHE II score                       17 ± 6                 16 ± 6                0.818\*      0.418
  SOFA score                            8 ± 5                  6 ± 5                 1.432\*      0.159
  Sedation and analgesics use/not use   29/9                   26/14                 1.200^†^     0.273
  Vasoactive drug use/not use           31/7                   34/6                  0.164^†^     0.685
  Surgical/nonsurgical admission        30/8                   27/13                 1.298^†^     0.255
  Indication for ICU stay, *n* (%)                                                                
   Sepsis                               35 (92)                34 (85)               0.964^†^     0.326
   Pancreatitis                         1 (3)                  1 (2.5)               0.001^†^     0.971
   Trauma                               0 (0)                  2 (5)                 1.950^†^     0.163
   SIRS without infection               2 (5)                  3 (7.5)               0.163^†^     0.687
  Medical history, *n* (%)                                                                        
   Hypertension                         11 (29)                6 (15)                2.224^†^     0.136
   Diabetes mellitus                    5 (13)                 4 (10)                0.190^†^     0.663
   COPD                                 8 (21)                 6 (15)                0.485^†^     0.486
  Ventilation                                                                                     
   Tidal volume (ml/kg)                 7.8 ± 1.3              7.6 ± 1.9             0.383\*      0.525
   Plateau pressure (cmH~2~O)           22.1 ± 3.3             20.8 ± 2.6            1.577\*      0.122
   PEEP (cmH~2~O)                       6.7 ± 2.6              6.0 ± 1.7             1.125\*      0.267
   Intra-abdominal pressure (cmH~2~O)   12.2 ± 3.9             11.9 ± 3.4            0.288\*      0.774
  Cardiac function                                                                                
   GEF (%)                              12 ± 2                 26 ± 3                −16.246\*    0.000
   dp/dt max (mmHg/s)                   946 ± 390              1346 ± 357            −3.624\*     0.001
   CFI (L/min)                          3.6 ± 0.8              7.4 ± 0.4             −19.363\*    0.000
   CPO (W)                              0.31 ± 0.13            0.48 ± 0.15           −4.363\*     0.000
  Hemodynamics                                                                                    
   GEDV (ml)                            737 ± 190              695 ± 103             0.912\*      0.369
   CVP (mmHg)                           7 ± 1                  5 ± 2                 2.382\*      0.023
   Lac (mmol/L)                         3.5 ± 2.8              3.3 ± 2.4             0.271\*      0.788
   HR (beats/min)                       110 ± 11               110 ± 16              0.128\*      0.899
   SAP (mmHg)                           98 ± 10                117 ± 14              −5.201\*     0.000
   DAP (mmHg)                           57 ± 8                 53 ± 12               1.485\*      0.145
   MAP (mmHg)                           71 ± 8                 74 ± 10               −1.157\*     0.254
   PP (mmHg)                            41 ± 12                64 ± 16               −5.654\*     0.000
   SV (ml)                              40 ± 15                61 ± 20               −4.002\*     0.000
   CO (L/min)                           4.2 ± 1.4              6.6 ± 1.9             −4.761\*     0.000

Values were shown as mean ± SD, *n*, or *n* (%). \**t* values; ^†^*χ*^2^ values. GEF: Global ejection fraction; APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; ICU: Intensive Unit Care; SIRS: Systemic inflammatory response syndrome; COPD: Chronic obstructive pulmonary disease; CHD: Coronary heart disease; PEEP: Positive end-expiratory pressure; CFI: Cardiac function index; CPO: Cardiac power output; GEDV: Global end-diastolic volume; CVP: Central venous pressure; Lac: Lactic acid; HR: Heart rate; SAP: Systolic arterial pressure; DAP: Diastolic arterial pressure; MAP: Mean arterial pressure; PP: Radial pulse pressure; SV: Stroke volume; CO: Cardiac output; SD: Standard deviation.

Hemodynamic changes during passive leg raising and volume expansion {#sec2-7}
-------------------------------------------------------------------

In the low-GEF (\<20%) group, 25 patients were considered responders, with an increase in SV of 15% or more after VE. In the near-normal-GEF (≥20%) group, 26 patients were considered responders. The hemodynamic parameters at each step of the protocol (baseline 1, during PLR, baseline 2, and after VE) are shown in [Table 2](#T2){ref-type="table"}. Within each group, hemodynamic parameters were identical at baseline 1 and baseline 2. There were no significant differences between responders and nonresponders at baseline, with the exception of higher SAP/MAP values in nonresponders of the low-GEF group and higher CO/SV and lower PP in nonresponders of the near-normal-GEF group. After PLR and VE, the hemodynamic parameters showed significant changes in responders but not in nonresponders \[[Table 2](#T2){ref-type="table"}\]. Values of PLR-Δ are shown in [Supplementary Table 1](#T3){ref-type="table"}. All index changes in the near-normal-GEF group were significantly higher in responders than in nonresponders, except for PLR-ΔPP, while in the low-GEF group, only PLR-ΔSV and PLR-ΔCO were significantly higher in responders.

###### 

Hemodynamic parameters at each step of the protocol in responders and nonresponders in each group

  Parameters       GEF \<20% (*n* = 38)   GEF ≥20% (*n* = 40)                     
  ---------------- ---------------------- --------------------- ----------------- --------------
  SV (ml)                                                                         
   Base 1          38 ± 17                47 ± 10               51 ± 12\*         79 ± 21
   PLR             43 ± 19^†^             50 ± 10^†^            60 ± 14\*^,†^     83 ± 20^†^
   Base 2          38 ± 17                48 ± 11               51 ± 12\*         79 ± 20
   Post-VE         46 ± 19^‡^             50 ± 10               63 ± 14\*^,‡^     82 ± 20^‡^
  HR (beats/min)                                                                  
   Base 1          112 ± 11               101 ± 7               115 ± 15          102 ± 16
   PLR             111 ± 12\*             97 ± 9                111 ± 13^†^       101 ± 13
   Base 2          114 ± 12\*             101 ± 6               115 ± 15\*        102 ± 15
   Post-VE         109 ± 11\*             98 ± 6                105 ± 14^‡^       101 ± 15
  SAP (mmHg)                                                                      
   Base 1          95 ± 10\*              106 ± 9               119 ± 13          111 ± 13
   PLR             108 ± 9^†^             113 ± 12              134 ± 23\*^,†^    112 ± 13
   Base 2          96 ± 9\*               107 ± 9               120 ± 13          111 ± 11
   Post-VE         114 ± 9^‡^             111 ± 11              136 ± 20\*^,‡^    121 ± 10^‡^
  MAP (mmHg)                                                                      
   Base 1          69 ± 8\*               76 ± 6                73 ± 10           76 ± 9
   PLR             79 ± 10                81 ± 9                86 ± 12^†^        77 ± 8
   Base 2          69 ± 8                 76 ± 6                73 ± 11           76 ± 7
   Post-VE         83 ± 11                80 ± 7                88 ± 11^‡^        84 ± 9^‡^
  PP (mmHg)                                                                       
   Base 1          39 ± 13                45 ± 10               68 ± 15\*         54 ± 15
   PLR             42 ± 12                48 ± 11               73 ± 23^†^        55 ± 16
   Base 2          39 ± 11                45 ± 10               70 ± 14\*         54 ± 15
   Post-VE         47 ± 11^‡^             47 ± 11               74 ± 20\*^,‡^     57 ± 14
  CO (L/min)                                                                      
   Base 1          4.1 ± 1.6              4.7 ± 0.8             5.9 ± 1.5\*       7.9 ± 2.1
   PLR             4.5 ± 1.8^†^           4.8 ± 0.8             6.6 ± 1.6\*^,†^   8.3 ± 2.0^†^
   Base 2          4.1 ± 1.6              4.8 ± 1.0             5.9 ± 1.5\*       8.0 ± 2.1
   Post-VE         4.8 ± 1.8^‡^           4.8 ± 0.9             6.6 ± 1.5\*^,‡^   8.3 ± 2.0^‡^

Values were shown as mean ± SD. \**P*\<0.05 versus nonresponders; ^†^*P*\<0.05 versus baseline 1; ^‡^*P*\<0.05 versus baseline 2. GEF: Global ejection fraction; CO: Cardiac output; HR: Heart rate; SAP: Systolic arterial pressure; MAP: Mean arterial pressure; PP: Radial pulse pressure; SV: Stroke volume; PLR: Passive leg raising; VE: Volume expansion; SD: Standard deviation.

###### 

Hemodynamic changes induced by PLR and VE in responders and nonresponders in each group

  Items      GEF \<20% (*n* = 38)   GEF ≥20% (*n* = 40)                                                         
  ---------- ---------------------- --------------------- ------- ------- -------------- ------------- -------- -------
  PLR-ΔSV    14.7 ± 5.7%            6.4 ± 5.3%            4.304   0.000   18.2 ± 5.8%    7.2 ± 5.9%    5.651    0.000
  PLR-ΔCO    11.2 ± 7.5%            3.4 ± 2.3%            3.454   0.001   12.3 ± 6.7%    3.9 ± 3.4%    4.359    0.000
  PLR-ΔHR    −0.9 ± 3.7%            −1.2 ± 4.9%           0.219   0.828   −6.0 ± 4.2%    −1.6 ± 3.0%   −3.341   0.002
  PLR-ΔSAP   11.2 ± 7.8%            7.9 ± 6.5%            1.308   0.199   11.6 ± 8.8%    5.0 ± 2.7%    2.737    0.009
  PLR-ΔMAP   10.5 ± 7.7%            6.3 ± 2.9%            1.848   0.073   13.9 ± 11.3%   5.2 ± 3.1%    2.801    0.008
  PLR-ΔPP    10.4 ± 8.1%            5.9 ± 4.8%            0.744   0.454   8.0 ± 6.8%     4.3 ± 3.4%    0.863    0.073
  VE-ΔSV     20.8 ± 5.5%            5.0 ± 3.7%            8.347   0.000   22.5 ± 5.4%    4.8 ± 4.1%    11.558   0.000

GEF: Global ejection fraction; PLR: Passive leg raising; PLR-ΔSV: PLR-induced change in stroke volume; PLR-ΔCO: PLR-induced change in cardiac output; PLR-ΔHR: PLR-induced change in heart rate; PLR-ΔSAP: PLR-induced change in systolic arterial pressure; PLR-ΔMAP: PLR-induced change in mean arterial pressure; PLR-ΔPP: PLR-induced change in pulse pressure; VE: Volume expansion; VE-ΔSV: VE-induced change in stroke volume.

Correlations and receiver-operating characteristic curves {#sec2-8}
---------------------------------------------------------

The correlation between PLR-Δ and VE-ΔSV is shown in [Table 3](#T4){ref-type="table"}. Regardless of GEF, PLR-ΔSV and PLR-ΔCO were positively correlated with VE-ΔSV. In addition, PLR-ΔHR was negatively correlated with VE-ΔSV in the near-normal-GEF (≥20%) group. None of the other variables were correlated with VE-ΔSV in either group. The areas under the ROC curves (AUC) for all index changes in the near-normal-GEF group were greater than the corresponding changes in the low-GEF group. The highest AUC values were for PLR-ΔSV (0.860 ± 0.059) and PLR-ΔCO (0.840 ± 0.063) in the low-GEF group and for PLR-ΔSV (0.942 ± 0.038) and PLR-ΔCO (0.859 ± 0.063) in the near-normal-GEF group \[[Table 3](#T4){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}\].

###### 

Diagnostic accuracy of index changes induced by PLR for predicting fluid responsiveness

  Items       GEF \<20% (*n* = 38)                                                                                                                            
  ----------- ------------------------- --------- --------------- ------------------- --------------------- --------------------- ------------- ------------- ----
  ΔSV         0.539                     0.000     0.860 ± 0.059   0.000               8                     92                    70            85            82
  ΔCO         0.494                     0.002     0.840 ± 0.063   0.001               6                     80                    77            87            67
  ΔHR         −0.096                    0.568     0.457 ± 0.100   0.667               −1                    52                    54            70            39
  ΔSAP        0.217                     0.192     0.628 ± 0.091   0.113               6                     76                    62            79            57
  ΔMAP        0.273                     0.098     0.662 ± 0.091   0.106               7                     64                    77            84            53
  ΔPP         0.205                     0.216     0.502 ± 0.100   0.998               6                     56                    54            70            39
                                                                                                                                                              
  **Items**   **GEF ≥20% (*n* = 40)**                                                                                                                         
                                                                                                                                                              
  ***r***     ***P***                   **AUC**   ***P***         **Threshold (%)**   **Sensitivity (%)**   **Specificity (%)**   **PPV (%)**   **NPV (%)**   
                                                                                                                                                              
  ΔSV         0.698                     0.000     0.942 ± 0.038   0.000               12                    92                    86            92            84
  ΔCO         0.712                     0.000     0.859 ± 0.063   0.000               7                     81                    86            91            71
  ΔHR         −0.533                    0.000     0.799 ± 0.071   0.002               −5                    65                    93            94            60
  ΔSAP        0.196                     0.225     0.776 ± 0.073   0.004               5                     69                    78            86            58
  ΔMAP        0.249                     0.121     0.769 ± 0.075   0.005               7                     69                    72            82            57
  ΔPP         0.220                     0.212     0.624 ± 0.090   0.202               5                     62                    79            84            52

GEF: Global ejection fraction; PLR: Passive leg raising; PLR-ΔSV: PLR-induced change in stroke volume; PLR-ΔCO: PLR-induced change in cardiac output; PLR-ΔHR: PLR-induced change in heart rate; PLR-ΔSAP: PLR-induced change in systolic arterial pressure; PLR-ΔMAP: PLR-induced change in mean arterial pressure; PLR-ΔPP: PLR-induced change in pulse pressure; PPV: Positive predictive value; NPV: Negative predictive value; *r*: Correlation coefficient between PLR-Δ and VE-ΔSV; AUC: Area under the receiver operation characteristics curve.

![ROC curves comparing the ability of PLR-induced changes to discriminate responders from nonresponders regarding volume expansion in the GEF \<20% group (a) and GEF ≥20% group (b). PLR: Passive leg raising; ROC: Receiver-operating characteristic; GEF: Global ejection fraction.](CMJ-131-253-g002){#F2}

Diagnostic performance of fluid responsiveness {#sec2-9}
----------------------------------------------

In practical terms, the optimum threshold values and associated sensitivities and specificities for distinguishing fluid responders from nonresponders are presented in [Table 3](#T4){ref-type="table"}. In total, the index changes in the GEF ≥20% group showed better predicting ability than those in the GEF \<20% group. The thresholds of PLR-ΔSV and PLR-ΔCO for predicting fluid responsiveness were higher in the GEF ≥20% group than in the GEF \<20% group (ΔSV: 12% vs. 8%; ΔCO: 7% vs. 6%), with increased sensitivity (ΔSV: 92% vs. 92%; ΔCO: 81% vs. 80%) and specificity (ΔSV: 86% vs. 70%; ΔCO: 86% vs. 77%), respectively. Regarding PLR-ΔHR, this value could predict fluid responsiveness in the GEF ≥20% group, with a threshold value of −5% (sensitivity 65%, specificity 93%), but could not do so in the GEF \<20% group. The other pressure index changes, ΔSAP, ΔMAP, and ΔPP, showed poor ability to predict fluid responsiveness \[[Table 3](#T4){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}\].

![PLR-induced changes in stroke volume (ΔSV), cardiac output (ΔCO) and heart rate (ΔHR) in responders and nonresponders in the GEF \<20% group (a, *n*=38) and the GEF ≥20% group (b, *n*=40). PLR: Passive leg raising; GEF: Global ejection fraction.](CMJ-131-253-g003){#F3}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Our study suggests that the diagnostic value of PLR depends on the systolic cardiac function in ventilated patients in the ICU. PLR-ΔSV and PLR-ΔCO enabled accurate bedside prediction of fluid responsiveness regardless of whether cardiac function of the patients is normal (GEF ≥20%) or lower (GEF \<20%), but the threshold, sensitivity, and specificity were lower in the GEF \<20% group. In addition, PLR-ΔHR could predict fluid responsiveness in the GEF ≥20% group but not in the GEF \<20% group, while pressure index changes were poorly able to predict fluid responsiveness.

Hypovolemia is a very frequent clinical situation in the ICU and is primarily treated with VE. Unfortunately, only 40--70% of critically ill patients with acute circulatory failure display a significant increase in SV or CO in response to VE.\[[@ref1]\] In patients with septic shock, fluid infusion is usually recommended\[[@ref26]\] but may be harmful particularly in patients with acute respiratory distress syndrome.\[[@ref27][@ref28]\] PLR as a simple, economic, noninvasive, and reversible self-VE can help ICU staff avoid fluid infusion in patients who could be harmed by fluid overload.\[[@ref29][@ref30][@ref31]\] Recently, Monnet *et al*.\[[@ref32]\] performed a systematic review and meta-analysis including 21 studies and concluded that PLR very reliably predicted volume responsiveness. However, none of these studies evaluated the systolic cardiac function of patients, so it remained unknown whether systolic cardiac function could influence the diagnostic accuracy of PLR. Therefore, we designed this study to explore the accuracy of PLR for detecting fluid responsiveness in patients with low or normal cardiac function.

Echocardiography is the gold standard for left ventricular ejection fraction (LVEF) estimation. However, the measurement of LVEF in ICU patients is commonly performed through bedside transthoracic echocardiography (TTE), and the quality of TTE is influenced by many factors such as mechanical ventilation. Thus, by providing cardiac function indices, the PiCCO system could provide an interesting alternative to echocardiography in the assessment of LVEF. Four previous studies validated GEF as an indicator of LVEF in critically ill ICU patients. Combes *et al*.\[[@ref20]\] demonstrated in thirty patients that GEF was correlated with LVEF assessed by transesophageal echocardiography (*r* = 0.82; *P* \< 0.0001). A similar correlation was described in 2009 by Jabot *et al*.\[[@ref21]\] from F/LVEF measurements (*r* = 0.67; *P* \< 0.0001) involving 39 patients where LVEF was obtained by TTE. Meybohm *et al*.\[[@ref33]\] and Perny *et al*.\[[@ref34]\] also suggested that GEF was significantly correlated with LVEF. Trof *et al*.\[[@ref23]\] studied the effect of systolic cardiac function on cardiac filling volumes versus pressures for predicting fluid responsiveness by dividing patients into a low-GEF group (\<20%) and a near-normal-GEF group (≥20%). However, the authors studied the effect of systolic function on static hemodynamic indices but not on dynamic indices. In our study, we also divided patients into a low-GEF group (\<20%) and a near-normal-GEF group (≥20%). In fact, the GEF value was 12 ± 2% in the GEF \<20% group, which was significantly lower than that (26 ± 3%) in the GEF ≥20% group. The other indices of SV, CO, CFI, CPO, and dp/dt max were also significantly lower in the GEF \<20% group, which demonstrated the significant difference in systolic cardiac function between the two groups.

In our study, the threshold value and diagnostic accuracy of PLR to predict fluid responsiveness were dependent on systolic cardiac function. Both PLR-ΔSV and PLR-ΔCO enabled accurate bedside prediction of fluid responsiveness regardless of cardiac function, but the threshold, sensitivity, specificity, and AUC were all higher in the near-normal-GEF group (≥20%) than in the low-GEF group (\<20%). According to the Frank--Starling curve, two zones can be distinguished: (a) a slope where minimum preload changes give rise to a marked increase in SV (preload dependency zone) and (b) a flat or level segment where the SV hardly varies with changes in preload (preload-independent zone). Therefore, the relationship between the changes in SV depends on the baseline of preload and morphology or the gradient of the curve, which are determined by the contractile capacity of the heart. Thus, different patients show different Frank--Starling curves because of varied cardiac function, indicating different responses to the same preload increase. In our study, the baseline GEDV was 737 ± 190 ml in GEF \<20% group versus 695 ± 103 ml in GEF ≥20% group which means that there were no significant differences between the two groups (*P* = 0.369) in terms of baseline of preload. The patients were divided into a near-normal-GEF group and a low-GEF group, showing different Frank--Starling curves between the two groups. Our results also demonstrated that the threshold in the near-normal-GEF group was higher (ΔSV: 12% vs. 8%; ΔCO: 7% vs. 6%) than that in the low-GEF group. Interestingly, the threshold values of PLR-ΔCO were less than those of PLR-ΔSV regardless of cardiac function, which brought our attention to PLR-ΔHR. We found that PLR-ΔHR in the near-normal-GEF group and the low-GEF group were different. The decrease in HR (−6.0 ± 4.2%; *P* = 0.002) was statistically significant in responders but not in nonresponders of the GEF ≥20% group, and HR was not found to be altered in responders or nonresponders of the GEF \<20% group. In addition, in the GEF ≥20% group, PLR-ΔHR was negatively correlated with VE-ΔSV (*r* = −0.533, *P* = 0.000). The threshold value of PLR-ΔHR for predicting fluid responsiveness was −5% using ROC analysis with acceptable sensitivity (65%) and high specificity (93%). However, in the GEF \<20% group, PLR-ΔHR could not predict fluid responsiveness. This finding may be because (a) the parasympathetic component of baroreceptor regulation of HR was impaired in patients with cardiac dysfunction\[[@ref35]\] or (b) the overstimulation of sympathetic nerves was inconsistent with the inhibition of the vagal nerve in patients with left ventricle dysfunction, which leads to uncoordinated control of autonomic nervous system and sinoatrial node, resulting in a disorder of HR regulation.\[[@ref36]\] Préau *et al*.\[[@ref17]\] also concluded that PLR-ΔHR was statistically significant (−2.0 ± 4.0%; *P* \< 0.05) in responders, but they included few patients with low LVEF and did not distinguish between groups of patients. These authors stated that the observed decrease in HR was very small and thus had no impact. The use of pressure index changes, such as PLR-ΔPP, ΔSAP, and ΔMAP, as preload responsiveness markers is based on the hypothesis that they depend on SV. During each systole, the left ventricle ejects a variable amount of blood through the systemic arterial circulation generating PP, SAP, and MAP waves along the arterial tree. However, all these pressure indices are influenced by complex properties of the systemic arterial tree, such as arterial compliance, wave propagation, and wave reflection. Monnet *et al*.\[[@ref32]\] concluded that, when PLR effects are assessed by changes in PP, the specificity of the PLR test remains acceptable but its sensitivity is poor; Préau *et al*.\[[@ref17]\] also found that the accuracy of ΔSAP and ΔMAP for predicting fluid responsiveness is lower. In our study, all these pressure indices were poorly able to predict fluid responsiveness, which is consistent with previous studies.

Our study has some limitations. First, we used GEF \<20% monitored by PiCCO to distinguish patients with cardiac dysfunction. The accuracy of GEF is lower than LVEF measurements by TTE or TEE, especially in patients with valvular regurgitation. However, previous studies have demonstrated a significant correlation between GEF and LVEF. Second, we defined fluid responsiveness as an increase in SV ≥15% with VE; this cutoff value was chosen in reference to previous studies.\[[@ref32]\] Although this cutoff seems clinically relevant, the predictive value of PLR may be altered if another cutoff value were chosen. In addition, the VE for definition of fluid responsiveness might be influenced by cardiac function. For patients with cardiac dysfunction, the influence would never be eliminated only if the VE was performed when the cardiac function has been improved to the normal level. However, it is very difficult to titrate cardiac function with inotropic agents. Third, nearly one-third of patients were not given analgesic and sedative drugs during PLR, which may cause vital signs to fluctuate due to sympathetic arousal. However, PLR is a less sympathetic stimulation for these patients who were more compatible and tolerated endotracheal intubation. In addition, there was no statistically significant difference in the proportion of patients without analgesic and sedative drugs between the two groups, which further reduced the possibility of experimental and result errors caused by sympathetic arousal. Finally, the study population was small but similar to previous PLR studies, so a large-scale study must be conducted to confirm these findings.

In conclusion, our study demonstrated that the diagnostic value of PLR depends on cardiac systolic function in ventilated patients in the ICU. PLR-ΔSV and PLR-ΔCO enabled accurate bedside prediction of volume responsiveness regardless of whether cardiac function of the patients is normal or lower, but the threshold, sensitivity, and specificity were lower in the GEF \<20% group. In addition, PLR-ΔHR could predict fluid responsiveness in the GEF ≥20% group but not in the GEF \<20% group, while pressure index changes were poorly able to predict fluid responsiveness. These findings suggest that, when using PLR for predicting fluid responsiveness, cardiac systolic function must be considered a factor influencing the diagnostic accuracy of PLR.

*Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website*.

Financial support and sponsorship {#sec2-10}
---------------------------------

This work was supported by the grants from the Fundamental Research Funds for the Central Universities (No. 15ykpy14) and Sun Yat-sen University Clinical Research 5010 Program (No. 2007015).

Conflicts of interest {#sec2-11}
---------------------

There are no conflicts of interest.

**Edited by:** Yuan-Yuan Ji

[^1]: Xiang Si and Dai-Yin Cao contributed equally to this work.
